A solid-phase immunofluorometric assay was evaluated for the identification of viruses isolated in tissue culture, with influenza virus as a model. Purified immunoglobulin G (IgG) from hyperimmune rabbit sera specific for contemporary strains of influenza A or B was covalently attached to microscopic plastic beads to capture virus. Fluorescein isothiocyanate (FITC)-conjugated antibodies of different specificities were then reacted with bound antigen, and the resulting complexes were quantified in a suitable filter fluorometer. The assay, with appropriately absorbed FITC-conjugated second antibody, reliably identified virus present in harvests from cell cultures infected with clinical specimens. For influenza A (HlNt) virus, sensitivity of detecting antigen was about 8-to 32-fold less when an FITC-conjugated monoclonal IgG antibody pool specific for epitopes in three different antigenic sites on influenza hemagglutinin was used as the second antibody as compared to when IgG from hyperimmune sera specific for virus or its components was used as the second antibody. The immunofluorometric assay provides a method for quantitative detection of viral antigen in tissue culture fluids and objective identification of virus type and subtype with FITC-conjugated reagents.
There are three approaches to the laboratory diagnosis of viral infection, namely, the isolation of infectious virus from clinical specimens, the direct detection of viral antigens in clinical specimens, and the detection of virus-specific antibodies in the convalescent phase of sera of infected persons under circumstances where these are believed to be due to recent infection. Each of these approaches is amenable to the application of immunoassay procedures which might, under some circumstances, provide worthwhile advantages compared with other tests for the presence of antigen or antibody (13, 21) . When traditional approaches of virus isolation are not possible, immunoassays become the accepted methods for diagnosis, e.g., with hepatitis B virus-associated antigens (and antibodies) (6) and noncultivable human gastroenteritis viruses (9) . Before traditional methods which are successful with other viruses are replaced by immunoassays, however, it is desirable to evaluate thoroughly the many different immunoassay strategies that are available so that procedures which are practical enough for general use are developed. Such evaluations should take account of not only the procedures but also the selection of reagents.
Recently, we showed that a solid-phase immunofluorometric assay (IFMA) provided a specific, sensitive, and reproducible method for measuring the reactions of monoclonal antibodies and influenza viruses (10, 16) . We have now evaluated this procedure for the identification of viral isolates, with influenza virus as a model because of the availability of diverse immunological reagents. Thus, as a part of the evaluation, we have studied the relative usefulness of monoclonal antibodies versus antibody from heterogeneous animal sera for detection of viral antigen in an immunoassay.
MATERIALS AND METHODS Antisera. Preparation of influenza A/Texas/1/77 (H3N2), A/Brazil/llM8 (HlNl), and B/Hong Kong/l/ 78 virion hyperimmune antisera in rabbits and of ascitic fluids from mice inoculated with mouse hybridomas producing monoclonal antibodies reactive with these influenza hemagglutinins (HA) was previously described (16, 19) .
The hybridoma antibodies against A/USSRI9o/77 used here were previously characterized for their class, subclass, and avidity, as well as the distinctiveness of the antigenic sites containing epitopes that they recognize (10, 15) . From these earlier results, it is known that the pool of monoclonal antibodies studied here included immunoglobulin G (IgG) species W/18 and 70/1, which had avidities comparable to those of polyclonal antibodies in mature, heterogeneous animal antisera (dissociation constants ranging from 2.3 x 10-l to 2.8 x 10-l) (10) . Furthermore, those monoclonal antibodies were shown to react with epitopes in two distinct sites in the Hi HA molecule (15) . A third antibody incorporated in the pool, 110, has a dissociation constant of 34 x 10-1 and binds to an additional site within the Hi HA molecule (10, 15 tissue culture infective doses was adsorbed onto washed monolayers at 37°C for 1 h. The infected MDCK cells were maintained in Eagle modified medium (3) containing 2 p,g of tolylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-trypsin per ml (Worthington Diagnostics, Freehold, N.J.). At 2 days postinfection, the cells and fluids were frozen and thawed three times, and after sedimentation of the cell debris, the supernatant fluids were stored in aliquots at -70°C until needed.
Influenza virus isolates from clinical specimens (throat washings or swabs) were recovered by inoculating 0.1 ml of specimen into each of three tubes (10 by 150 mm) containing MDCK monolayers and incubating with tolylsulfonyl phenylalanyl chloromethyl ketone-trypsin medium. Tissue culture fluid samples were removed from the culture tubes on days 2, 3, 5, and 7 for IFMA, hemagglutination, and infectivity analysis.
Viral infectivity and HA titrations. Viral infectivity was determined from plaque titrations carried out in MDCK cells as previously described (3). Hemagglutination and hemagglutination inhibition (HI) tests were done by the microtiter method with 0.5% chicken erythrocytes (5). Specimens containing influenza and noninfluenza respiratory virus isolates from RMK cells were provided, under code, by John Hierholzer.
Solid-phase immunoassay for antigen detection. DEAE-purified antibody specific for whole virus was covalently coupled to 1.1-,um polyaminostyrene beads (16) . This provided a large surface area of solid-phase antibody which was used to bind the viral antigens present in 0.1-ml samples of egg or tissue culture harvests. Detection and measurement of specific antigens were then achieved with a second FITC-labeled specific antibody and a filter fluorometer with a digital readout (Spectra/Glo; Gilson Medical Electronics, Inc., Middleton, Wis.), respectively. The highest dilution of conjugate producing plateau fluorescence was considered to be the optimal dilution for each conjugate, and this dilution was determined by titration in the IFMA with beads saturated with homologous antigen. Details for preparing the solid-phase influenza reactants and for performing the IFMA have been previously described (10, 16, 17) and are summarized in Fig. 1 1.5 in. (3 to 4 cm) in a water bath for reaction steps, and centrifuged (e.g., in a Sorvall GLC-4 instrument). During wash procedures, tubes are held in place in the carrier by threading latex rubber tubing along the spaces between each row of tubes. This permits draining of reagents and wash solutions by inverting the entire racks. The need to handle individual tubes, up until the time they are read in the filter fluorometer, can thereby be eliminated, minimizing the time requirements for performing washing procedures for the solid-phase immunoassay.
The coefficient of variation of the procedure was established in earlier studies for a range of fluorescent intensities and, in the critical range approaching background, wa: about 6% (10). Earlier studies also demonstrated that the sensitivity of detecting binding by hybridoma antibodies to influenza A Hi HA was not related to the subclass or avidity of the IgG antibodies, when compared to HI testing (10 Step 2: Virus-specific antigens in 0.1-ml volumes of tissue culture harvests are captured by reaction with 0.1 ml (3.7 x 107) of antibody-coated beads at 37°C for 1 h.
Step 3: A 0.05-ml amount of optimally diluted FITC-conjugated antiviral antibody is reacted at 37°C for 1 h with the captured viral antigen, and excess conjugate is removed by three washes. The beads are recovered by centrifugation at 1,500 x g for 15 min after each wash.
Step 4: Bound conjugate is detected with a filter fluorometer.
fluorescence they each produced when detecting antigens of their homologous viruses grown in MDCK cells. To enhance the availability of all virus-specific antigens in the IFMA, the MDCK cell cultures were frozen and thawed before harvesting the tissue culture medium. With each of the three viruses, the fluorescent intensity was found to be greatest for the antibody conjugate prepared against whole virus and least for a pool of three HA-specific monoclonal antibodies, as shown for the influenza HlNl strain (Fig.  2) . Intermediate levels of fluorescent responses were obtained with antibodies from animals hyperimmunized with purified HA or nucleoprotein. Qualitatively similar findings (not shown) were observed with reagents prepared with influenza A (H3N2) and influenza B virus, in that fluorescent responses were always greatest with antibody against whole virus and least with monoclonal antibody pools.
The potentially greater sensitivity of the antiwhole virus conjugates over that of conjugates to viral components for detecting virus antigen was further examined for the HlNl virus. Different FITC conjugate preparations were compared in the solid-phase assay with increasingly diluted influenza A (HlNl) virus antigen. The hyperimmune antibody conjugates detected vi- rus-specific antigen (i.e., had a fluorescent response greater than twice the background) when virus was diluted about 32 to 128 times, whereas the monoclonal antibody conjugate pool could not detect antigen when virus was diluted more than about 8 times. Thus, although background levels of fluorescence were higher when unabsorbed conjugated IgG from heterogeneous animal serum, rather than conjugated monoclonal antibodies, was used in the assay (Fig. 2) , the conjugate prepared from anti-whole virus hyperimmune serum had the highest sensitivity for detecting the presence of virus. Anti-whole virus conjugates therefore were used for the remainder of the study.
Specfficity of IFMA for identification of influenza isolates grown from clinical specimens.
Cross-testing of three anti-whole virus conjugates with homologous and heterologous antigens revealed the existence of low-level reactions between influenza A and B reagents that are not explicable on the basis of known antigenic relationships between the viruses. The low- was not undertaken for rapid viral diagnosis, but as a model to evaluate the performance of an objective fluorometric assay in the identification of tissue culture virus isolates, we chose to apply the IFMA to samples obtained from cells exhibiting traditional markers of virus replication, as described above. Nevertheless, it was of interest to estimate the relative amounts of virus necessary for detection in the immunoassay. For this purpose, several of the above-described isolates from MDCK cells were inoculated into flasks of MDCK cells for plaque titration on the same day that they were tested by IFMA. Specimens with low virus concentrations were also tested by including a few samples collected early (2 to 3 days) after infection of an MDCK cell culture with a clinical specimen, at which time cytopathic effect or hemagglutination was not detected. No attempt was made to compare the IFMA with microscopic examination of fluorescent antibody-stained cells because of the lack of objective quantitation possible in the latter technique.
All samples of MDCK harvests containing more than 103 PFU per 0.1 ml produced significant fluorescent responses when tested by IFMA (Fig. 4) With the most broadly reactive conjugates prepared with heterogeneous antibody from animals immunized with purified whole viruses, we were able to detect influenza viruses grown in tissue culture from clinical specimens when virus titers exceeded approximately 103 PFU per 0.1 ml of tissue culture fluid. However, it may be misleading to use infectivity determination as the final criterion when determining the sensitivity for detecting antigen, because tissue culture fluids probably contain noninfectious virus and viral components released from the tissue culture cells in excess quantities, in addition to infectious virus particles. Further studies are needed to evaluate whether the assay has a sufficient sensitivity to detect influenza virus antigens present in optimally collected clinical specimens.
Immunoassays may not offer real practical advantages over other procedures for rapid diagnosis in respiratory, or some other, virus infections. For example, fluorescence microscopy with antibody-labeled epithelial cells recovered from nasal specimens has been shown by several authors to be a quick and effective way of identifying many of the common respiratory viruses, including influenza (4, 11, 14) , provided that adequate reagents are available. In some specific cases, however, immunoassays have the potential to provide worthwhile improvements over current identification techniques, particularly those requiring time-consuming neutralization assays. The model study that we have performed with influenza virus indicates that the IFMA should be considered among the approaches available for developing immunoassays to this end.
